Brief: Pila Pharma H2 EBIT Loss Narrows To SEK 3.8 Mln

Pila Pharma AB

10/02/2026 07:34

Feb 10 (Reuters) - Pila Pharma AB PILA.ST:

H2 OPERATING INCOME AMOUNTED TO TSEK 276 (107)

H2 EBIT TOTALED TO TSEK -3 802 (-4 030)

Source text: ID:nBQNXTGX7

Further company coverage: PILA.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))